The earliest date of detecting Grade 3 or worse toxicity was recorded.
Further information (name, date of birth, school grade and type of school) were obtained in documents provided by the school.
Parameters recorded include date of birth, histological grade, tumour size, tumour type, lymph node status, lymphovascular invasion (LVI), date of diagnosis, date of relapse, date of last follow-up, and date and cause of death.
The following data necessary for this study were collected: patients age at the time of diagnosis, height and weight, tumor histology and grade, date of cytoreductive surgery, date of disease progression, date of last visit, date of death.
With the approval of the institutional review boards data regarding patients' age, histology, TNM stage, tumor grade, date of diagnosis, date of metastasizing and date of death were recorded.
Demographic data, tumor characteristics (date of incidence, stage and grade at diagnosis) and treatment data (actual treatment given and location of treatment), as well as survival were determined in a reliable manner.
The following demographic characteristics were analysed: gender, date of birth, date of registration, grade of CPO (grades 1 4 according to Jensen et al. [ 17]; Fig. 1), presence of syndromes and/or congenital anomalies, delivery location, GA and the age at diagnosis of CPO.
Therefore, our instrument comprised the following sections and format: (i) Demographics; A brief section seeking information about sex, date of birth, age, and school grade level.
End of follow-up was the earliest of: date of diagnosis of high-grade CIN, date of treatment, or date of last visit.
The following information will be collected: date of onset, nature, severity graded on a scale from 1 to 4 (minor, moderate, severe, and life-threatening), seriousness, relationship with AL, action(s) taken, date of resolution, outcome.
